It’s looking mighty unlikely they’re going get near blogs after the Zubillaga scandal.
Related posts:
- Big Pharma bowing to the power of blogs
- "Buckets of cash" affair and MedImmune
- Drug companies and medical malpractice
- Richard Reece’s favorite blogs
- Official instructions to move your bowels
- Patient blogs: A HIPAA nightmare?
- LA Times on medical blogs
KevinMD.com on Facebook
Comments on this entry are closed.